Suzuki M - Search Results

1

Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft model.

Yamazaki M, Kato A, Oki E, Zaitsu Y, Kato C, Nakano K, Nakamura M, Sakomura T, Kawai S, Fujii E, Sawada N, Watanabe T, Saeki H, Suzuki M. Yamazaki M, et al. Among authors: suzuki m. Lab Invest. 2021 Jan;101(1):12-25. doi: 10.1038/s41374-020-0471-y. Epub 2020 Jul 29. Lab Invest. 2021. PMID: 32728120 Free article.

2

Combination of fixation using PLP fixative and embedding in paraffin by the AMeX method is useful for histochemical studies in assessment of immunotoxicity.

Suzuki M, Katsuyama K, Adachi K, Ogawa Y, Yorozu K, Fujii E, Misawa Y, Sugimoto T. Suzuki M, et al. J Toxicol Sci. 2002 Aug;27(3):165-72. doi: 10.2131/jts.27.165. J Toxicol Sci. 2002. PMID: 12238140 Free article.

3

Histopathological study on the PTHrP-induced incisor lesions in rats.

Kato A, Suzuki M, Karasawa Y, Sugimoto T, Doi K. Kato A, et al. Among authors: suzuki m. Toxicol Pathol. 2003 Sep-Oct;31(5):480-5. doi: 10.1080/01926230390224665. Toxicol Pathol. 2003. PMID: 14692615

4

Histopathological study of time course changes in PTHrP-induced incisor lesions of rats.

Kato A, Suzuki M, Karasawa Y, Sugimoto T, Doi K. Kato A, et al. Among authors: suzuki m. Toxicol Pathol. 2005;33(2):230-8. doi: 10.1080/01926230590906530. Toxicol Pathol. 2005. PMID: 15902966

5

PTHrP and PTH/PTHrP receptor 1 expression in odontogenic cells of normal and HHM model rat incisors.

Kato A, Suzuki M, Karasawa Y, Sugimoto T, Doi K. Kato A, et al. Among authors: suzuki m. Toxicol Pathol. 2005;33(4):456-64. doi: 10.1080/01926230590959604. Toxicol Pathol. 2005. PMID: 16036863

6

Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.

Azuma Y, Ishikawa Y, Kawai S, Tsunenari T, Tsunoda H, Igawa T, Iida S, Nanami M, Suzuki M, Irie RF, Tsuchiya M, Yamada-Okabe H. Azuma Y, et al. Among authors: suzuki m. Clin Cancer Res. 2007 May 1;13(9):2745-50. doi: 10.1158/1078-0432.CCR-06-2919. Clin Cancer Res. 2007. PMID: 17473208

7

Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin.

Kimura K, Tabo M, Itoh M, Mizoguchi K, Kato A, Suzuki M, Itoh Z, Omura S, Takanashi H. Kimura K, et al. Among authors: suzuki m. J Toxicol Sci. 2007 Aug;32(3):217-30. doi: 10.2131/jts.32.217. J Toxicol Sci. 2007. PMID: 17785939 Free article.

8

Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.

Kimura K, Tabo M, Mizoguchi K, Kato A, Suzuki M, Itoh Z, Omura S, Takanashi H. Kimura K, et al. Among authors: suzuki m. J Toxicol Sci. 2007 Aug;32(3):231-9. doi: 10.2131/jts.32.231. J Toxicol Sci. 2007. PMID: 17785940 Free article.

9

Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study.

Fujii E, Kimura K, Mizoguchi K, Kato A, Takanashi H, Itoh Z, Omura S, Suzuki M. Fujii E, et al. Among authors: suzuki m. Toxicol Appl Pharmacol. 2008 Apr 1;228(1):1-7. doi: 10.1016/j.taap.2007.09.001. Epub 2007 Sep 11. Toxicol Appl Pharmacol. 2008. PMID: 18355581

10

Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model.

Kato A, Matsuo S, Takai H, Uchiyama Y, Mihara M, Suzuki M. Kato A, et al. Among authors: suzuki m. Exp Mol Pathol. 2008 Jun;84(3):262-70. doi: 10.1016/j.yexmp.2008.03.003. Epub 2008 Apr 3. Exp Mol Pathol. 2008. PMID: 18511040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,504 results

Search Page

Filters